Labeling for Permanent Hysteroscopically-Placed Tubal Implants Intended for Sterilization: Guidance for Industry and Food and Drug Administration Staff
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 31, 2016
February 9, 2019
90c1f1b9-1a53-417f-8d58-7605e596a3a6
Related Documents
Public Notification of Emerging Postmarket Medical Device Signals ("Emerging Signals"): Guidance for Industry and Food and Drug Administration Staff
Guidance DocumentDecember 14, 2016Center for Devices and Radiological Health
Implanted Blood Access Devices for Hemodialysis: Guidance for Industry and Food and Drug Administration Staff
Guidance DocumentJanuary 21, 2016Center for Devices and Radiological Health
Recommendations for Premarket Notifications for Lamotrigine and Zonisamide Assays: Guidance for Industry and Food and Drug Administration Staff
Guidance DocumentFebruary 9, 2016Center for Devices and Radiological Health
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox